Description:
The National Institute of Dental and Craniofacial Research invites the small business community to apply cutting edge-technology to the design and development of novel delivery systems for rapid and/or sustained, on-demand release of therapeutic agents (e.g. antimicrobial, anti-inflammatory, antibodies, peptides, nucleotides, small molecule receptor agonists/antagonists) in the oral cavity. This PA uses the SBIR phase I and phase II (R43, R44) and the phase I and phase II STTR (R41, R42) mechanisms. Thus, only small business concerns are eligible to submit applications.
Who can apply:
Private Institutions Of Higher Education
Small Business (Less Than 500 Employees
Eligible functional categories:
Funding Sources:
Discovery and Applied Research
Oral Diseases and Disorders Research
More Information:
http://grants.nih.gov/grants/guide/pa-files/PA-05-087.html
If you have problems accessing the full announcement, please contact:
NIH OER Webmaster
Address Info: